Toxoplasmosis in Cats: Risks to Pregnant Women and Immunocompromised Individuals

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii [1, 2]. The definitive hosts for T. gondii are members of the family Felidae, including domestic cats, which are the only species capable of excreting environmentally resistant oocysts in their feces [2, 3]. This excretory capacity positions cats as the central reservoir in the epidemiology of toxoplasmosis, with a single infected cat shedding millions of oocysts that can remain infective for extended periods [2, 3]. Humans, particularly pregnant women and immunocompromised individuals, are at risk of acquiring infection through accidental ingestion of oocysts from contaminated environments [3, 4]. The clinical consequences of acute toxoplasmosis during pregnancy include congenital transmission leading to fetal morbidity, while in immunocompromised patients, reactivation of latent infection can cause life-threatening encephalitis or disseminated disease [5, 6]. This article provides a detailed examination of the biological, diagnostic, and control aspects of feline toxoplasmosis, with a focus on risks to these vulnerable human populations.

Etiology and Life Cycle

Toxoplasma gondii exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts) [2, 7]. Cats acquire infection primarily by ingesting tissue cysts containing bradyzoites from intermediate hosts (e.g., rodents, birds) or by ingesting sporulated oocysts from the environment [2, 8]. After ingestion, the parasite undergoes enteroepithelial replication in the feline small intestine, culminating in the production of unsporulated oocysts that are shed in feces [2, 7]. The prepatent period ranges from 3 to 10 days after ingestion of tissue cysts, but may be longer (up to 19 days or more) after oocyst ingestion [2, 8]. Oocyst shedding typically lasts 1 to 3 weeks, although re-shedding can occur under immunosuppressive conditions [2, 7].

Following sporulation in the environment (1 to 5 days under favorable aerobic conditions), oocysts become infective and can survive for months in soil, water, and on surfaces [2, 3]. The life cycle completes when a new definitive or intermediate host ingests sporulated oocysts [2]. In cats, after the initial intestinal phase, tachyzoites disseminate to various tissues and form tissue cysts predominantly in the brain, skeletal muscle, and heart, establishing a chronic, latent infection [9, 7]. The persistence of tissue cysts in cats is lifelong [2, 10].

Epidemiology and Risk Factors

Seroprevalence of T. gondii in domestic cats varies widely by geographic region, lifestyle, age, and health status [2, 11, 34]. Studies using serological methods such as ELISA, indirect immunofluorescence (IFAT), and modified agglutination tests have reported prevalence rates ranging from 6% in Turkey [1] to 37.8% in stray cats from Izmir, Turkey [12], 20.8% in Greece [34], 37.4% in Slovakia [4], and up to 74.6% in stray cat populations in Pakistan [13]. A study in Egypt isolated viable parasites from 85.7% of seropositive cats, demonstrating high tissue burden [14].

Risk factors for seropositivity include outdoor access, older age, history of cat-fight trauma, lack of vaccination, and stray or semi-domesticated status [11, 13, 34]. Semi-domesticated cats in Bangkok had 8.34 times higher odds of infection compared to pet cats [11]. Stray cats living in crowded environments with poor sanitation exhibit higher oocyst shedding rates [13, 12, 15]. A study in Pakistan found a significantly higher prevalence in older cats (>4 years) and those in poor body condition [13]. In Greece, lack of vaccination against core feline viruses was a strong independent risk factor (odds ratio 10), suggesting that overall health management influences susceptibility to T. gondii [34].

The role of stray cats in environmental contamination is critical. Fecal PCR studies in Izmir, Turkey, detected T. gondii DNA in 14.37% of stray cat feces, indicating active shedding [12]. Oocyst detection by microscopy in the same study was only 0.43%, highlighting the superior sensitivity of molecular methods [12]. High contamination has been reported in markets and urban gardens in Brazil and Indonesia, respectively [3, 15]. Feral cat populations thus serve as a continuous source of oocysts for both animal and human infections [12, 35].

Clinical Signs in Cats

Most T. gondii infections in cats are subclinical [2, 16]. Clinical disease occurs more frequently in young kittens, immunocompromised cats, and those infected with highly virulent genotypes [16, 33]. A large retrospective study of 100 histologically confirmed cases (1952-1990) characterized the spectrum of disease: 36% had generalized toxoplasmosis, 26% pulmonary, 16% abdominal, 7% neurologic, 9% neonatal, and 2% cutaneous [9]. Common clinical signs include fever (73% of cases with recorded temperatures), dyspnea, polypnea, abdominal discomfort, anorexia, and lethargy [9, 17].

Ocular toxoplasmosis is a frequent manifestation, with 81.5% of histologically examined eyes showing intraocular inflammation, most commonly multifocal iridocyclochoroiditis [9, 18, 16]. Neurological signs such as ataxia, seizures, and behavioral changes have been documented, often associated with cerebral and spinal cord involvement [19, 9]. Pulmonary toxoplasmosis presents as interstitial pneumonia, often with rapid progression to respiratory failure [9, 20]. Neonatal toxoplasmosis can result in stillbirth, neonatal death, or multisystemic disease in kittens [20, 33]. A case report of two littermate kittens that succumbed to acute primary toxoplasmosis associated with ToxoDB genotype #4 confirmed that even healthy kittens can experience overwhelming disseminated infection when exposed to a high tissue-cyst burden, often linked to raw meat feeding [33].

Pathology

Gross and histological lesions reflect tachyzoite-induced necrosis and inflammation in affected organs [9, 16]. In generalized toxoplasmosis, lesions are multifocal and include necrotic foci in the liver, lungs, pancreas, and lymph nodes [9, 35]. Pulmonary lesions are characterized by interstitial pneumonia with alveolar necrosis, fibrinous exudate, and tachyzoites within type II pneumocytes and macrophages [9]. Hepatic lesions show multifocal necrotizing hepatitis [9]. The central nervous system exhibits non-suppurative meningoencephalitis with microglial nodules, gliosis, and perivascular cuffing [9, 35].

Ocular lesions involve the uvea, particularly the ciliary body, with lymphoplasmacytic infiltration and occasional tachyzoites in the retina and choroid [9, 16]. In Pallas' cats, encephalitis is a predominant lesion, while ring-tailed lemurs frequently show lymphoid tissue involvement [35]. Chronically infected cats harbor tissue cysts in brain and muscle without accompanying inflammation [9, 7].

Diagnostics

Antemortem diagnosis relies on a combination of serological, molecular, and cytological methods, complemented by clinical signs [1, 16]. Serological tests detect antibodies to T. gondii, but positive serology alone does not confirm active disease due to high chronic infection rates [2, 10]. The modified agglutination test using formalin-preserved tachyzoites is considered highly sensitive for detecting exposure in cats [10]. Commercial ELISA kits for IgG and IgM are widely used; IgM detection suggests recent or acute infection [13, 21]. Indirect immunofluorescence (IFAT) is also employed, with sensitivity and specificity varying by antigen [3, 34].

Recombinant antigens such as GRA7 have shown superior sensitivity for serodiagnosis in cats compared to SAG2 or GRA6 [21]. A study comparing these antigens found that GRA7-based ELISA had the highest diagnostic accuracy [21]. The Sabin-Feldman dye test is the gold standard but requires live tachyzoites and is rarely performed in clinical veterinary settings [10].

Molecular diagnostics, particularly conventional or real-time PCR, enable direct detection of T. gondii DNA in blood, feces, aqueous humor, or tissues [13, 16, 12]. Fecal PCR is more sensitive than microscopy for detecting oocysts [12]. PCR from cerebrospinal fluid or bronchoalveolar lavage can support diagnoses of neurological or pulmonary toxoplasmosis [16, 17].

Cytological examination of tracheal aspirates, pleural fluid, or lymph node aspirates may reveal tachyzoites, but sensitivity is low [9, 16]. Immunohistochemical staining of biopsy or necropsy tissues using anti-T. gondii antibodies provides definitive confirmation of infection [9, 33].

Rapid immunochromatographic tests offer convenience for point-of-care screening, with acceptable sensitivity compared to ELISA, as demonstrated in a prevalence study using rapid kits on 50 cats, which identified a 6% prevalence [1]. However, the same study noted that cats with clinical signs compatible with toxoplasmosis could still test negative, reinforcing the need for confirmatory testing [1].

The following decision tree illustrates a diagnostic workflow for a cat with suspected toxoplasmosis:

flowchart TD
    A[Cat with clinical signs\nfever, dyspnea, uveitis, neuro signs], > B{Serology (ELISA/IFAT)\nIgG/IgM}
    B, >|IgG+, IgM-| C[Chronic infection\nconsider other causes or\nconcurrent disease]
    B, >|IgG+, IgM+| D[Recent/active infection]
    B, >|IgG-, IgM-| E[Unlikely active toxoplasmosis\nevaluate other etiologies]
    D, > F{PCR on blood,\nfeces, or CSF}
    F, >|Positive| G[Confirm active toxoplasmosis\nbegin therapy]
    F, >|Negative| H[High suspicion? consider\ncytology/repeat PCR\nor treat empirically]
    G, > I[Monitor response;\nre-check serology/PCr]

Treatment

Treatment is indicated for cats with clinical toxoplasmosis [16, 5]. The standard protocol involves clindamycin hydrochloride at 10-12 mg/kg orally every 12 hours for 4 weeks [22, 16, 32]. Clindamycin reduces tachyzoite replication and improves clinical outcomes, but does not eliminate tissue cysts [22, 5]. A paradoxical effect of clindamycin was reported in experimental acute toxoplasmosis in cats, where treated cats showed prolonged oocyst shedding but fewer clinical signs, possibly due to altered immune response [22]. Prophylactic clindamycin has been used successfully in Pallas' cat kittens to reduce mortality from toxoplasmosis from 71.6% to 5.88% [32].

Alternative or adjunctive therapies include trimethoprim-sulfonamide combinations, azithromycin, and pyrimethamine, although clindamycin remains the first-line agent for feline toxoplasmosis [16, 5]. Combination therapy with folinic acid is recommended when pyrimethamine is used to prevent bone marrow suppression [16].

Supportive care (fluid therapy, nutritional support, oxygen therapy for respiratory cases) is essential in severe cases [16]. For ocular toxoplasmosis, topical corticosteroids may be used cautiously after systemic antiprotozoal therapy to control inflammation [9, 16].

Control and Prevention of Zoonotic Transmission

Because cats are the only definitive hosts, controlling environmental contamination with oocysts is central to reducing human infection risks [2, 3]. Pregnant women and immunocompromised individuals should adopt stringent hygiene measures when handling cats or cleaning litter boxes [6, 5]. Key recommendations include:

• Daily litter box cleaning, as oocysts require 1-5 days to sporulate and become infective [2, 5].
• Wearing disposable gloves and washing hands thoroughly after any contact with cat feces or litter [5].
• Keeping cats indoors to prevent hunting of intermediate hosts and ingestion of tissue cysts [11, 12].
• Feeding cats only commercial cooked or canned food; avoiding raw meat diets [2, 33].
• Covering children's sandboxes to prevent cat defecation [5].
• Pregnant women should ideally delegate litter box duties to another household member [5, 6].

Stray cat population control, including trap-neuter-return programs, reduces the number of stray cats shedding oocysts [11, 12, 35]. In zoo settings, strict feral cat and rodent control is essential to prevent outbreaks in highly susceptible species such as Pallas' cats and ring-tailed lemurs [32, 35].

Vaccination of cats against T. gondii is not commercially available worldwide, but experimental live attenuated vaccines (e.g., RHΔompdcΔuprt) have shown promise in reducing oocyst shedding by 95.3% and inducing strong humoral and cell-mediated immunity in cats [23]. However, no licensed vaccine currently exists for routine use in cats [2, 23].

Education of cat owners about the risks of toxoplasmosis and simple preventive measures is critical for public health [4, 6]. Seroprevalence surveys using sentinel cats can help monitor environmental contamination levels [4, 24]. A study using sentinel chickens demonstrated that cats can serve as indicators of T. gondii presence on farms, with implications for food safety [24].

Conclusion

Feline toxoplasmosis presents a significant zoonotic risk, particularly for pregnant women and immunocompromised individuals, due to the unique ability of cats to shed infectious oocysts [2, 3, 5]. The disease in cats ranges from subclinical to fatal, with pulmonary, neurologic, and ocular forms being most severe [9, 16]. Accurate diagnosis requires a combination of serology, PCR, and clinical assessment [1, 16]. Treatment with clindamycin is effective for active disease but does not clear the carrier state [22, 5]. Prevention relies on environmental hygiene, responsible pet ownership, and stray cat management [11, 12]. Continued research into vaccines and more sensitive diagnostic tools will further mitigate the public health burden of this widespread parasite.

References

[1] Parlatir, Y., Senel, Y., & Kara, E. (2025). Determination of the Prevalance of Toxoplasmosis in Cats with Immunochoromatographic Rapid Tests Kits in Kirikkale University Veterinary Faculty Animal Hospital. Research and Practice in Veterinary and Animal Science. https://www.semanticscholar.org/paper/247f3db5fd827af96d636da4d3164d751074874f

[2] Dubey, J., Cerqueira-Cezar, C. K., Murata, F., et al. (2020). All about toxoplasmosis in cats: the last decade. Veterinary Parasitology. https://www.semanticscholar.org/paper/f0acbbba7cd9f8c048d5d0764bbf9a13fc7c158b

[3] Fux, B., Covre, K., Lopes, R., et al. (2020). Seroprevalence of Toxoplasmosis in Cats in Espirito Santo State, Brazil. Current Developments in Nutrition. https://www.semanticscholar.org/paper/c8a06a7c2da069a70425a4ee3b10947240fb5aca

[4] Selyemova, D., Antolova, D., Mangova, B., et al. (2024). Cats as a sentinel species for human infectious diseases – toxoplasmosis, trichinellosis, and COVID-19. Current Research in Parasitology and Vector-Borne Diseases. https://www.semanticscholar.org/paper/ce0b02c41d9424f9078cf916d5152566094d337a

[5] Frenkel, J. K. (1978). Toxoplasmosis in cats: diagnosis, treatment and prevention. Comparative Immunology, Microbiology & Infectious Diseases. https://www.semanticscholar.org/paper/83342586a02084c5abca00f2f74a7c8eaed91393

[6] Hasan, M. F., Harun, A., Hossain, D., et al. (2024). Toxoplasmosis in animals and humans: a neglected zoonotic disease in Bangladesh. Journal of Parasitic Diseases. https://www.semanticscholar.org/paper/da821e8fdfc168c67e0410f9698f8797db223dfc

[7] Dubey, J. (1986). Toxoplasmosis in cats. Journal. https://www.semanticscholar.org/paper/2d40c71cd859696150a18a7a02da5c18e19cb9f6

[8] Dubey, J., & Frenkel, J. K. (1972). Cyst-induced toxoplasmosis in cats. The Journal of Protozoology. https://www.semanticscholar.org/paper/12c02c2160648955e5516f3c6df5f8ca6fc8d0c9

[9] Dubey, J., & Carpenter, J. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association. https://www.semanticscholar.org/paper/d52209abc2a6337a4c9d08f712a537010200385e

[10] Dubey, J., & Thulliez, P. (1989). Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. Journal of the American Veterinary Medical Association. https://www.semanticscholar.org/paper/ee22536cb0d4e9d5bd35bdcff522943c207f2843

[11] Inpankaew, T., Sattasathuchana, P., Kengradomkij, C., et al. (2021). Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand. BMC Veterinary Research. https://www.semanticscholar.org/paper/9d019b6566281c83eacd73785646da54fbe4f464

[12] Karakavuk, M., Can, H., Selim, N., et al. (2021). Investigation of the role of stray cats for transmission of toxoplasmosis to humans and animals living in Izmir, Turkey. Journal of Infection in Developing Countries. https://www.semanticscholar.org/paper/d4034b4469c570f968226bd0f2428a8841127668

[13] Majid, A., Ahmad, N., Haleem, S., et al. (2021). Detection of toxoplasmosis in pets and stray cats through molecular and serological techniques in Khyber Pakhtunkhwa, Pakistan. BMC Veterinary Research. https://www.semanticscholar.org/paper/8d881c294db66470f8cb1039711b82f9beddee6c

[14] Al-Kappany, Y., Rajendran, C., Ferreira, L. R., et al. (2010). High Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate Designation. Journal of Parasitology. https://www.semanticscholar.org/paper/eb0cb3755cb9a332123f4cff955b60832811f357

[15] Zakaria, R., & Ardiansyah, S. (2020). Potential Analysis Of Toxoplasmosis Distribution In Wild Cats (Felis silvestris) In Some Markets Of Sidoarjo District Through Microscopic Identification Of Toxoplasma gondii.

[16] Calero-Bernal, R., & Gennari, S. (2019). Clinical Toxoplasmosis in Dogs and Cats: An Update. Frontiers in Veterinary Science. https://www.semanticscholar.org/paper/85289202e785e3bc73f8f5115e9316d859714c0c

[17] Bastan, I. (2018). Clinical and some laboratory findings in cats with Toxoplasmosis. Journal. https://www.semanticscholar.org/paper/22a23aba5dc5ed1ccad8996586a2a1622e64a857

[18] Vainisi, S. J., & Campbell, L. H. (1969). Ocular toxoplasmosis in cats. Journal. https://www.semanticscholar.org/paper/249b39e2a160380e0392f576ba6c852d4525e72d

[19] Cucos, C., Ionascu, I., Mocanu, J., et al. (2015). Neurological and ocular form of toxoplasmosis in cats. Journal. https://www.semanticscholar.org/paper/aa122640585a7963211031f376cc4dfc5aad4bb2

[20] Dubey, J., Mattix, M., & Lipscomb, T. (1996). Lesions of Neonatally Induced Toxoplasmosis in Cats. Veterinary Pathology-Supplement. https://www.semanticscholar.org/paper/1254e6ad6e3a8af547409537637842df2c9baaf2

[21] Sabukunze, S., Gu, H., Zhao, L., et al. (2024). Comparison of the performance of SAG2, GRA6, and GRA7 for serological diagnosis of Toxoplasma gondii infection in cats. Frontiers in Veterinary Science. https://www.semanticscholar.org/paper/9f5d168c43119aed8d92f0b3115eb05d8db3dc99

[22] Davidson, M. G., Lappin, M., Rottman, J. R., et al. (1996). Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrobial Agents and Chemotherapy. https://www.semanticscholar.org/paper/3c33146daf33215dac6e658719c1d07bb266fdf7

[23] Shen, Y., Zheng, B., Sun, H., et al. (2023). A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infectious Diseases of Poverty. https://www.semanticscholar.org/paper/2c0eccd9ce92a1acbb4617baa6621f2d56e59c5e

[24] Dubey, J. P., Lehmann, T., Lautner, F., et al. (2015). Toxoplasmosis in sentinel chickens (Gallus domesticus) in New England farms: Seroconversion, distribution of tissue cysts in brain, heart, and skeletal muscle by bioassay in mice and cats. Veterinary Parasitology. https://www.semanticscholar.org/paper/42d3ddc4b9f40d6e02a8ef8aaaa90d909dc2fbf7

[25] Munhoz, A., Hage, S. B., Cruz, R., et al. (2017). Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Veterinary Parasitology: Regional Studies and Reports. https://www.semanticscholar.org/paper/7c8a2fdd2e9561c2569bc4e98397bbe347e630a2

[26] Ahmad, N., Ahmed, H., Irum, S., et al. (2014). Seroprevalence of IgG and IgM antibodies and associated risk factors for toxoplasmosis in cats and dogs from sub-tropical arid parts of Pakistan. Tropical Biomedicine. https://www.semanticscholar.org/paper/da6e18e25d3ce94af78a72a188b4814bde5a4bf6

[27] Shahzad, A., Khan, M. S., Ashraf, K., et al. (2006). Sero-epidemiological and haematological studies on toxoplasmosis in cats, dogs and their owners in Lahore, Pakistan. Journal. https://www.semanticscholar.org/paper/7d0dfdee60bdf59fcc72a83a2c3ef69c3c975815

[28] Dubey, J. P., Hoover, E., & Walls, K. (1977). Effect of age and sex on the acquisition of immunity to toxoplasmosis in cats. The Journal of Protozoology. https://www.semanticscholar.org/paper/23dc34fe496f694a558cf945c5ed25693529c1dd

[29] Zafar, Z., Ali, N., & Baleanu, D. (2021). Dynamics and numerical investigations of a fractional-order model of toxoplasmosis in the population of human and cats. Journal. https://www.semanticscholar.org/paper/db91c7fb65e1a1d56be21460221b7855e2809a5c

[30] Germano, P. M., Melo, H., Bianchin, I., et al. (1980). Toxoplasmosis in cats and dogs. Journal. https://www.semanticscholar.org/paper/28ba5dd1a8560109667f0cde4939e26be92466a8

[31] Vinogradov, L. I. (1980). Diagnosis of toxoplasmosis in cats. Journal. https://www.semanticscholar.org/paper/547f904162fe1e9133e7b8fbdd7c56c7fd520f18